|
LV5616A3
|
|
Attempt to obtain N-naphthoyl glycine derivatives
|
|
LT2592B
|
|
N- (6-metoxy-5 (perfloralkil) -1-naftoyl) -n-methyllycin or tionaftoilic analyzes as aldozoreductaese inhibitors
|
|
LT2621B
|
|
The n-naphylglicin dental receipt
|
|
US5206018A
|
|
Use of rapamycin in treatment of tumors
|
|
CA1236480B
|
|
N-naphthoylglycine derivatives
|
|
IE850023L
|
|
Stereospecific microbial reduction
|
|
EP0148612A2
|
|
A stereospecific microbial reduction
|
|
US4604406A
|
|
N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their thionaphthoyl analogs
|
|
CA1248127A
|
|
N-((6-(lower alkoxy)-5-trifluoromethylthio)-1- naphthalenyl)-thioxomethyl)-n-(lower alkyl)glycines
|
|
CA1188318A
|
|
N-(substituted-naphthoyl)glycine derivatives
|
|
CA1246068A
|
|
1-substituted-4h-¬1,2,4|-triazolo¬3,4-c|¬1, 4|benzoxazine derivatives
|
|
CA1232904A
|
|
Substituted pyrimidones with antifungal properties
|
|
US4521534A
|
|
Imidazo[2,1-a]pyrrolo[2,1-c][1,4]benzodiazepine derivatives, methods of preparation and use
|
|
US4521423A
|
|
7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them
|
|
IE832111L
|
|
Naphthalenylthiazole
|
|
US4492697A
|
|
4H-Imidazo[2,3-c]pyrido[2,3-e][1,4]oxazine derivatives
|
|
IE831481L
|
|
ß-ADRENOCEPTOR ANTAGONISTS AND ANXIOLYTIC AGENTS
|
|
US4499310A
|
|
5-Methyl-1-(trifluoromethyl)-2-naphthalenol, process for its preparation and ethers thereof
|
|
US4522946A
|
|
Dioxy hexahydrobenzo[6,7]cyclohepta[1,2,3-de]isoquinoline derivatives useful as neuroleptic agents
|
|
CA1229611A
|
|
Dioxy hexahydrobenzo[5,6]cyclohepta[1,2,3- de]isoquinoline derivatives
|
